191 related articles for article (PubMed ID: 21316556)
1. [Multidimensional impact of COPD exacerbations].
Soler-Cataluña JJ; Martínez-García MÁ; Serra PC
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():12-9. PubMed ID: 21316556
[TBL] [Abstract][Full Text] [Related]
2. [Impact of exacerbations on the clinical course of chronic obstructive pulmonary disease].
Soler-Cataluña JJ; Martínez-García MA; Catalán Serra P; Román Sánchez P
Rev Clin Esp; 2011 Mar; 211 Suppl 2():3-12. PubMed ID: 21596168
[TBL] [Abstract][Full Text] [Related]
3. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
Soler-Cataluña JJ; Rodriguez-Roisin R
COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
5. [Impact of exacerbations and admissions in chronic obstructive pulmonary disease].
Arnedillo Muñoz A
Arch Bronconeumol; 2010; 46 Suppl 8():8-14. PubMed ID: 21334550
[TBL] [Abstract][Full Text] [Related]
6. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
Niewoehner DE
Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
[TBL] [Abstract][Full Text] [Related]
7. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
[TBL] [Abstract][Full Text] [Related]
8. [Clinical phenotypes of COPD].
Sobradillo P; García-Aymerich J; Agustí À
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():8-11. PubMed ID: 21316555
[TBL] [Abstract][Full Text] [Related]
9. Practical management problems of chronic obstructive pulmonary disease in the elderly: acute exacerbations.
Abbatecola AM; Fumagalli A; Bonardi D; Guffanti EE
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S49-54. PubMed ID: 22209931
[TBL] [Abstract][Full Text] [Related]
10. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
11. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
[TBL] [Abstract][Full Text] [Related]
12. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
Trigueros Carrero JA
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
[TBL] [Abstract][Full Text] [Related]
13. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
Fan VS; Ramsey SD; Make BJ; Martinez FJ
COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
[TBL] [Abstract][Full Text] [Related]
14. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
Llor C; Molina J; Naberan K; Cots JM; Ros F; Miravitlles M;
Int J Clin Pract; 2008 Apr; 62(4):585-92. PubMed ID: 18266710
[TBL] [Abstract][Full Text] [Related]
15. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of COPD. Where are we now?].
Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL
Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549
[TBL] [Abstract][Full Text] [Related]
17. [Toward personalized and integrated treatment of patients with COPD].
Ancochea J; Gómez García T; de Miguel Díez J
Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551
[TBL] [Abstract][Full Text] [Related]
18. Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations.
Gillissen A; Glaab T; Lewis M; Buhl R; Worth H
J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():7-11. PubMed ID: 20134031
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.
Roche N; Rabbat A; Zureik M; Huchon G
Curr Opin Pulm Med; 2010 Mar; 16(2):112-7. PubMed ID: 20019614
[TBL] [Abstract][Full Text] [Related]
20. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
Dacydchenko SV; Bova AA
Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
